American Journal of Cardiology
Volume 103, Issue 2 , Pages 255-261 , 15 January 2009

Practice Variation Among Cardiovascular Physicians in Management of Patients With Mitral Regurgitation

  • Kevin M. Harris, MD

      Affiliations

    • Minneapolis Heart Institute Foundation at Abbott-Northwestern Hospital, Minneapolis, Minnesota
    • Corresponding Author InformationCorresponding author: Tel: 612-863-3900; fax: 612-863-2490
    • ,
  • Catherine A. Pastorius, BA

      Affiliations

    • Minneapolis Heart Institute Foundation at Abbott-Northwestern Hospital, Minneapolis, Minnesota
    • ,
  • Sue Duval, PhD

      Affiliations

    • Minneapolis Heart Institute Foundation at Abbott-Northwestern Hospital, Minneapolis, Minnesota
    • Division of Epidemiology and Community Health, University of Minnesota School of Public Health, Minneapolis, Minnesota
    • ,
  • Eileen Harwood, PhD

      Affiliations

    • Division of Epidemiology and Community Health, University of Minnesota School of Public Health, Minneapolis, Minnesota
    • ,
  • Timothy D. Henry, MD

      Affiliations

    • Minneapolis Heart Institute Foundation at Abbott-Northwestern Hospital, Minneapolis, Minnesota
    • ,
  • Blasé A. Carabello, MD

      Affiliations

    • Cardiovascular Division, Baylor College of Medicine, Houston, Texas
    • ,
  • Alan T. Hirsch, MD

      Affiliations

    • Minneapolis Heart Institute Foundation at Abbott-Northwestern Hospital, Minneapolis, Minnesota
    • Division of Epidemiology and Community Health, University of Minnesota School of Public Health, Minneapolis, Minnesota

Received 1 August 2008 ,Revised 9 September 2008 ,Accepted 9 September 2008.

References 

  1. American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease); Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons; Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr., Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Valvular Heart Disease). American College of Cardiology Web Site.
  2. Jamieson WRE, Cartier PC, Allard M, Boutin C, Burwash IG, Butany J, et al Surgical management of valvular heart disease 2004. Can J Cardiol. 2004;20:7E–120E
  3. Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, et al Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J. 2007;28:230–268
  4. Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, et al Recommendations for evaluation of the severity of native valvular regurgitation with 2-dimensional and Doppler echocardiography. J Am Soc Echocardiogr. 2003;16:777–802
  5. Wennberg JE, Fisher ES, Goodman DC, Skinner JS. Tracking the Care of Patients with Severe Chronic Illness: The Dartmouth Atlas for Health Care 2008. Lebanon, New Hampshire: The Dartmouth Institute for Health Policy and Clinical Practice Center for Health Policy Research, Dartmouth Medical School; 2008;Available at: http://www.dartmouthatlas.org/. Accessed June 14, 2008.
  6. Jones EC, Devereux RB, Roman MJ, Liu JE, Fishman D, Lee ET, et al. Prevalence and correlates of mitral regurgitation in a population-based sample (the Strong Heart Study). Am J Cardiol. 2001;87:298–304
  7. Society of Thoracic Surgeons. Executive Summaries and Sample Reports. www.sts.org/sections/stsnationaldatabase/publications/executive/article.htmlAccessed January 8, 2008
  8. Ling LH, Enriquez-Sarano M, Seward JB, Tajik AJ, Schaff HV, Bailey KR, et al. Clinical outcome of mitral regurgitation due to flail leaflet. N Engl J Med. 1996;335:1417–1423
  9. Grigioni F, Enriquez-Sarano M, Ling LH, Bailey KR, Seward JB, Tajik AJ, et al. Sudden death in mitral regurgitation due to flail leaflet. J Am Coll Cardiol. 1999;34:2078–2085
  10. Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, Detaint D, Capps M, Nkomo V, et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med. 2005;352:875–883
  11. Grigioni F, Tribouilloy C, Aviernos JF, Barbieri A, Ferlito M, Trojette F, et al. Outcomes in mitral regurgitation due to flail leaflets: a multicenter European study. J Am Coll Cardiol Img. 2008;1:133–141
  12. Grayburn PA. Should we operate on asymptomatic patients with severe mitral regurgitation?. J Am Coll Cardiol Img. 2008;1:142–144
  13. Rosenhek R, Rader F, Klaar U, Gabriel H, Krejc M, Kalbeck D, et al. Outcome of watchful waiting in asymptomatic severe mitral regurgitation. Circulation. 2006;113:2238–2244
  14. Carabello BA. Sudden death in mitral regurgitation: why was I so surprised?. J Am Coll Cardiol. 1999;34:2086–2087
  15. ACC/AHA guidelines for the management of patients with valvular heart disease (A report of the American College of Cardiology/American Heart Association. Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease)). J Am Coll Cardiol. 1998;32:1486–1588
  16. Toledano K, Rudski LG, Huynh T, Beique F, Sampalis J, Morin J. Mitral regurgitation: determinants of referral for cardiac surgery by Canadian cardiologists. Can J Cardiol. 2007;23:209–214
  17. Dujardin KS, Enriquez-Sarano M, Bailey KR, Seward JB, Tajik AJ. Effect of losartan on degree of mitral regurgitation quantified by echocardiography. Am J Cardiol. 2001;87:570–576
  18. Harris KM, Aeppli DM, Carey CF. Effects of angiotensin-converting enzyme inhibition on mitral regurgitation severity, left ventricular size, and functional capacity. Am Heart J. 2005;150:1106.e1–1106.e6
  19. Harris KM, Sundt TM, Aeppli D, Sharma R, Barzilai B. Can late survival of patients with moderate ischemic mitral regurgitation be impacted by intervention on the valve?. Ann Thorac Surg. 2002;74:1468–1475
  20. Grossi EA, Crooke GA, DiGiorgi PL, Schwartz CF, Jorde U, Applebaum RM, et al. Impact of moderate functional mitral insufficiency in patients undergoing surgical revascularization. Circulation. 2006;114:573–576
  21. Levine RA, Schwammenthal E. Ischemic mitral regurgitation on the threshold of a solution: from paradoxes to unifying concepts. Circulation. 2005;112:745–758
  22. Mihaljevic T, Lam BK, Rajeswaran J, Takagaki M, Lauer MS, Gillinov AM, et al. Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation. J Am Coll Cardiol. 2007;49:2191–2201
  23. Barzilai B, Gessler C, Perez JE, Schaab C, Jaffe AS. Significance of Doppler-detected mitral regurgitation in acute myocardial infarction. Am J Cardiol. 1988;61:220–223
  24. Lamas GA, Mitchell GF, Flaker GC, Smith SC, Gersh BJ, Basta L, et al. Clinical significance of mitral regurgitation after acute myocardial infarction (Survival And Ventricular Enlargement Investigators). Circulation. 1997;96:827–833
  25. Grigioni F, Enriquez-Saran M, Zehr KJ, Bailey KR, Tajik AJ. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation. 2001;103:1759–1764
  26. Pastorius CA, Henry TD, Harris KM. Long-term outcomes of patients with mitral regurgitation undergoing percutaneous coronary intervention. Am J Cardiol. 2007;100:1218–1223
  27. Pellizzon GG, Grines CL, Cox DA, Stuckey T, Tcheng JE, Garcia E, et al Importance of mitral regurgitation inpatients undergoing percutaneous coronary intervention for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. J Am Coll Cardiol. 2004;43:1368–1374
  28. Ellis SG, Whitlow PL, Raymond RE, Schneider JP. Impact of mitral regurgitation on long-term survival after percutaneous coronary intervention. Am J Cardiol. 2002;89:315–318

 This work was supported by the Minneapolis Heart Institute Foundation, Minneapolis, Minnesota.

PII: S0002-9149(08)01577-4

doi: 10.1016/j.amjcard.2008.09.065

American Journal of Cardiology
Volume 103, Issue 2 , Pages 255-261 , 15 January 2009

Article Tools

* Image Usage & Resolution